Current Opinion in Nephrology and Hypertension

Article	Citations
Dual organ transplantation: Pancreas and Liver in the kidney axis	49
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	34
Editorial introductions	33
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	31
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	28
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	27
Interferon gamma in the pathogenesis of hypertension − recent insights	23
Maximizing opportunities for kidney transplantation in older adults	21
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	20
The impact of conflicts on patients with chronic kidney disease	19
Microvascular inflammation in the kidney transplant, beyond acute antibody-mediated rejection	18
Evolution in the targets for blood pressure treatment	17
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	17
Modern indications for referral for kidney and pancreas transplantation	16
Editorial introduction	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	15
Prediction models for earlier stages of chronic kidney disease	15
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	15
Renal denervation for the treatment of hypertension and kidney disease	14
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	13
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	13
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	13
Plant-based diets for kidney disease prevention and treatment	13
International equity in access to home dialysis	13
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	13

Updates in tolerance: future directions to improve kidney allograft survival	12
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	12
Hypertension guidelines need to be patient oriented	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12
Built environment and chronic kidney disease: current state and future directions	12
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	12
Bringing the end-stage kidney disease life plan home	12
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	11
Understanding renal phosphate handling: unfinished business	11
The race coefficient in glomerular filtration rate-estimating equations and its removal	11
Complement detection in kidney biopsies – utility and challenges	11
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	11
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Lipocalin-2: a novel link between the injured kidney and the bone	10
Stopping renin–angiotensin–aldosterone system inhibitors in kidney disease	10
Editorial introductions	10
Combination therapy with kidney protective therapies: optimizing the benefits?	10
A guide for program development of environmentally sustainable kidney care	10
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	10
New advances in the diagnosis and pathologic spectrum of monoclonal gammopathy of renal significance	10
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	10
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	10
Editorial introductions	9
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
When the earth shakes unexpectedly: impact on nephrology services and patients	9
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Deep learning applications for kidney histology analysis	8
Implications of the cystatin C/creatinine discordance	8
Climate change and kidney stones	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	8
The current therapeutic approach for anaemia after kidney transplant	8
Automation and innovation in home hemodialysis machines	8
Paracellular transport along the nephron in physiology and pathophysiology	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	8
Update on antineutrophil cytoplasmic antibody vasculitis: Erratum	8
Renal osteodystrophy: something old, something new, something needed	7
Recent advances in treatment options for kidney disease	7
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	7
Sex differences in renal electrolyte transport	7
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	7
Prospects for gene therapy in polycystic kidney disease	7
Editorial introduction	7
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	7
Editorial introductions	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7

New insights into renal calcium-sensing receptor activation	7
Impact of intensive blood pressure control on kidney outcomes	7
Renal denervation: recent developments in clinical and preclinical research	7
Editorial introductions	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Evolving indications and management patterns in heart – kidney transplantation	6
New guidelines and therapeutic updates for the management of lupus nephritis	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
The genetics of cystinuria – an update and critical reevaluation	6
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
The changing trajectory of diabetic kidney disease	6
Screening for chronic kidney disease: change of perspective and novel developments	6
Early changes in kidney function in young adults: what is the significance?	6
Building kidney organoids from pluripotent stem cells	6
An update on the epidemiology of chronic kidney disease of uncertain etiology	6
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Novel approaches in antihypertensive pharmacotherapeutics	6
Peritoneal dialysis and heart failure	6
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	5
Time-limited trials for acute dialysis decision-making for critically ill older patients: rationale, communication strategies, and future research	5
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	5
Methotrexate nephrotoxicity: a pragmatic approach	5
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	5
Reimagining kidney value-based care: leveraging data science for dynamic, clinician-level risk prediction	5
Population health strategies for health equity in chronic kidney disease management	5
Targeting inflammation in hypertension	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
Electrolytes disturbances in cancer patients	5
Updated diagnostic and therapeutic management for membranous nephropathy	5
Medullary sponge kidney and chronic pain: is there a role for renal denervation	5
The role of calprotectin in vascular calcification	5
An update on corticosteroid treatment for IgA nephropathy	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Editorial introductions	5
WNK1 in the kidney	5
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	5
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	5
Diagnosing acute tubulointerstitial nephritis: novel biomarkers address an important clinical challenge	5
Novel agents for treating IgA nephropathy	5
Cystatin C should be routinely available for estimating kidney function	5
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	5
Chronic kidney disease and sex dimorphism	5
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	4
Progress in the management of patients with diabetes and chronic kidney disease	4
Home dialysis: there's no place like home	4
Editorial introductions	4
Tackling the epidemic of obesity and hypertension in children and young people	4
Use of water in dialysis and its impact on the environment	4
Pruritus in chronic kidney disease	4
Indications for and results of renal autotransplantation	4
Agents to treat osteoporosis in chronic kidney disease	4
The promise of artificial intelligence for kidney pathophysiology	4
Editorial introductions	4
Centering marginalized voices in advocacy for equitable policy change in kidney disease	4
Novel insights in the regulation of intercalated cell differentiation	4
Fibroblast growth factor 23, klotho and heparin	4
Implications of climate change on acute kidney injury	4
Postnatal renal tubule development: roles of tubular flow and flux	4
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	4
Climate change and its influence in nephron mass	4
The role of osteopontin in chronic kidney disease-mineral bone disorder	4
Updates on renal phosphate transport	4
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	4
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	4
Editorial introductions	4
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	4
Phosphate sensing in health and disease	4
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	4
Editorial introductions	3
Heating up: climate change and the threat to human health	3
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	3
New insights into clinical spectrum of antineutrophil cytoplasmic autoantibody associated disease	3
Novel pharmacological interventions for diabetic kidney disease	3

Social and humanitarian issues in nephrology and hypertension	3
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	3
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	3
SLC26A1 directs sulfate homeostasis in health and disease	3
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	3
Chronic kidney disease with unknown cause across the global spectrum	3
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	3
Kidney health and function with left ventricular assist devices	3
Justifying access to kidney care in low resource and humanitarian settings	3
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	3
Applications of cardiac biomarkers in chronic kidney disease	3
New pharmacological therapies for hypertension	3
APOL1 nephropathy – a population genetics success story	3
Artificial intelligence in kidney disease and dialysis: from data mining to clinical impact	3
The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions	3
Editorial introductions	3
Lysine and salt-sensitive hypertension	3
Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025	3
Update on antineutrophil cytoplasmic antibody vasculitis	3
Community acquired and hospital acquired AKI - two diseases divided by a common definition	3
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	3
Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation	3
Let's stop talking about ‘citrate toxicity’	3
Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease	3
Promises and limits of biopsy-based transcriptomics in kidney transplantation: a clinical utility perspective	3
The genetic spectrum of Gitelman(-like) syndromes	3
Do not forget about transplant patients during disasters	3
Mesenchymal/stromal cell therapy in kidney diseases: an update	3
Recent advances in the understanding of the peritoneal membrane	3
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	3